Clinical Trials Browser

Phase 2 × Pain × Radium-223 × Clear all

NCT02278055 2023-04-07

Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer

Phase 2 Completed

29 enrolled 10 charts

Pain, Prostatic Neoplasms